(1 - 21 from 23
)
Targeted TB treatment | News - Chemistry Worldwww.chemistryworld.com › news › targeted-tb-treatment- › article
www.chemistryworld.com
Geoff Coxon of Strathclyde University in the UK is director of medicinal chemistry for a newly formed body called Tuberculosis Drug Discovery UK.
[PDF] Global Health Commercialization & Funding Roundtable Reportwww.ifm.eng.cam.ac.uk › Events › GHCF_Roundtable_2012_Report
www.ifm.eng.cam.ac.uk
Cambridge, Geoff Coxon, Lecturer in Medicinal Chemistry, University of. Strathclyde / Tuberculosis Drug Discovery UK, Barry Furr, Llangarth Ltd,.
New TB treatment boost | Glasgow Times
www.glasgowtimes.co.uk
A BLUEPRINT for a much-needed new generation of tuberculosis treatment has been developed by a team of scientists led at Strathclyde University in…
sorted by relevance / date